Long time investor, retired from tech space
United States
Joined July 2020
- Tweets4.2K
- Following313
- Followers1.1K
- Likes1.7K
joe iniowa retweeted
Today, @HostDigital_ ($HOST) announced a $15 million share buyback program.
Our share price hasn’t changed the power available at Site I or the signed 15-year take-or-pay lease behind it. Our top priority remains financing, developing, and delivering our contracted projects.
joe iniowa retweeted
A megawatt on paper doesn’t do much for anybody. A megawatt that’s energized, leased, financed, built, and collecting rent is what creates value per share. That's our focus at @HostDigital_.
joe iniowa retweeted
Coya today announced plans to initiate an open-label extension (OLE) of the Phase 2/3 ALSTARS Trial evaluating COYA 302 for the treatment of amyotrophic lateral sclerosis (#ALS).
We plan to initiate the OLE in response to requests from ALSTARS investigators and study participants. “The strong interest from investigators and participants in continuing treatment beyond the current 48-week study period underscores the importance of providing continued access to COYA 302 for eligible participants in the ALSTARS trial,” said Dr. Fred Grossman, DO, FAPA, our President and Chief Medical Officer.
For more details: businesswire.com/news/home/2…
#EndALS
joe iniowa retweeted
$GANX just released 12 month data on Parkinsons Disease. Absolutely no progression on phase 1b patients MDS-UPDRS scores in a year, this is a massive win for PD! @ParkinsonDotOrg @ParkinsonsUK @ParkinsonFEP @parkinsons @CureParkinsonsT @MichaelJFoxOrg
joe iniowa retweeted
Lou! Did you see their news today? Crazy market kinda yawned. Seems important $GANX
joe iniowa retweeted
$GANX — Everyone talks “AI drug discovery,” but Gain is actually doing it. Their Magellan AI engine + physics‑based SDEET platform hunts misfolded proteins, maps hidden pockets, and engineers molecules that fix them. That’s how GT‑02287 was born. Real AI. Real enzyme rescue. Real Parkinson’s signal.
gaintherapeutics.com/science…
$GANX As our CEO says at some point it will be obvious we have stopped Parkinson's progression.
teapawt.net/i/status/2078868881238…
joe iniowa retweeted
“At nine months, it’s hard to ignore.” @GainThera CEO Gene Mack on the Parkinson’s signal that could redefine the $GANX story.
Early data. Small study. But huge potential stakes... for patients and investors.
Check out our latest update interview 👇
joe iniowa retweeted
If superman can't get $GANX the attention it deserves on early-stage results, no one can!
My dad, my hero, has been battling #Parkinson’s for decades @GainThera has been developing GT-02287, the possible first disease modifying drug for Parkinson’s. Congrats on today’s important milestone, receiving #FDA clearance of your IND allowing you to move to phase 2! $GANX
joe iniowa retweeted
$WULF signed a 20-year, nearly $20B deal with Anthropic for its Justified Data campus in Kentucky.
The campus will support ~401MW of critical IT load with initial capacity online in H2 2027 and full capacity expected by early 2028.
joe iniowa retweeted
We said we'd execute. Today we did.
Looking forward to joining @SullyCNBC on @CNBC's @PowerLunch this afternoon to talk about what's next.
$WULF 🐺
Don't miss it.
TeraWulf Chairman & CEO @PaulBPrager joins Brian Sullivan on CNBC's Power Lunch this Monday 🐺
He'll share his perspective on AI infrastructure, power markets and the opportunities shaping the next phase of growth.
Tune in. $WULF | @CNBC @SullyCNBC
joe iniowa retweeted
$WULF NEWS: TERAWULF ANNOUNCES ANTHROPIC LEASE AT JUSTIFIED DATA CAMPUS AND SALE OF MAJORITY INTEREST IN ABERNATHY JOINT VENTURE TO FLUIDSTACK
Long-Term AI Infrastructure Lease Expected to Generate ~$19 Billion of Contracted Revenue Over Initial Term
Abernathy Transaction Monetizes Approximately $450 Million Investment at a Premium and Provides Capital to Expand Wholly Owned AI Infrastructure Portfolio
investors.terawulf.com/news-…
joe iniowa retweeted
Don't miss it.
TeraWulf Chairman & CEO @PaulBPrager joins Brian Sullivan on CNBC's Power Lunch this Monday 🐺
He'll share his perspective on AI infrastructure, power markets and the opportunities shaping the next phase of growth.
Tune in. $WULF | @CNBC @SullyCNBC
joe iniowa retweeted
$GANX FDA clears IND for Parkinson's drug
— FDA authorized IND for GT-02287, clearing path to Phase 2 in Parkinson's disease (with or without GBA1 mutation), expected to start 3Q26
— Backed by Phase 1b data: all 16 extension patients still on study at Day 150, 81% reduction in CSF biomarker GluSph, motor score improvements in high-baseline patients
— Disease-modifying angle, not just symptomatic — drug targets the underlying GCase enzyme dysfunction tied to GBA1 mutations
— Phase 2a will run across US, Australia, Europe sites — small-cap biotech, binary risk into trial readouts as always
Not financial advice.
joe iniowa retweeted
FDA clears $GANX GT-02287 for Phase 2 in Parkinson’s; early data show safety and signs it may slow disease progression. notreload.xyz/xy/fda-clears-…
joe iniowa retweeted
$GANX - Gain Therapeutics Receives FDA Clearance of IND to Advance GT02287 into Phase 2 Clinical Development for Parkinsons Disease
IND authorization paves the way for initiation of GT-02287 Phase 2 clinical development in the U.S., expected during 3Q2… marketwirenews.com/stock/gan…
joe iniowa retweeted
Atomera developed a new GaN-on-silicon RF technology aimed at improving performance while lowering substrate costs. $ATOM says testing showed more than 10x lower parasitic interface charge and 1,000x better linearity than reference wafers at 30mW input power.
joe iniowa retweeted
Really Would Like To See $GANX at $100M -$150M Market Cap And Establish a New Floor. Need to Get Out of This Mid-High $1.00 Range
Im Shocked its Still Trading Here, But Thats Just More Opportunities For Retail
The Most Disconnected $1 Stock…
youtu.be/eOaInFFqPjE
joe iniowa retweeted
The Most Disconnected $1
Stock I’ve Ever Seen (Massive)
👉(youtu.be/eOaInFFqPjE)👈
joe iniowa retweeted
What if Parkinson’s didn’t have to get worse?
$GANX reported updated data showing no decline in motor scores – something rarely seen in this disease.
I sat down with CEO Gene Mack again to break it all down 👇
youtu.be/rYCfjSGm3RA
